PMC:7441788 / 6930-7561
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T24 | 52-57 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T25 | 357-361 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T59 | 21-29 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T60 | 32-41 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T61 | 229-237 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T62 | 474-482 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T63 | 533-541 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T67 | 45-57 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | VeroE6 cells |
T68 | 169-171 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
T69 | 189-191 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T70 | 240-248 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T71 | 357-361 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T72 | 485-493 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T73 | 559-567 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T80 | 75-77 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T81 | 252-254 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T82 | 450-452 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T83 | 514-516 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-MedDRA
Id | Subject | Object | Predicate | Lexical cue | meddra_id |
---|---|---|---|---|---|
T3 | 362-369 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | culture | http://purl.bioontology.org/ontology/MEDDRA/10061447 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T55 | 75-77 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T56 | 252-254 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T57 | 450-452 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T58 | 514-516 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T64 | 21-31 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
T65 | 229-239 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
T66 | 474-484 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
T67 | 533-541 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T55 | 194-283 | Sentence | denotes | These results showed that the anti-SARS-CoV-2 activity of CQ was worse than HCQ in vitro. |
T56 | 284-406 | Sentence | denotes | The conflicting results of these two studies may be related to different cell culture methods and experimental conditions. |
T57 | 407-494 | Sentence | denotes | In short, these in vitro studies show that CQ/HCQ have strong anti-SARS-CoV-2 activity. |
T58 | 496-498 | Sentence | denotes | 4. |
T59 | 500-541 | Sentence | denotes | Mechanisms of CQ/HCQ in treating COVID-19 |
T60 | 543-547 | Sentence | denotes | 4.1. |
T61 | 549-567 | Sentence | denotes | Antiviral activity |
T62 | 569-575 | Sentence | denotes | 4.1.1. |
T63 | 577-618 | Sentence | denotes | Hindrance of receptor recognition process |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
282 | 101-103 | Gene | denotes | μM | Gene:56925 |
284 | 450-456 | Gene | denotes | CQ/HCQ | |
285 | 155-157 | Gene | denotes | μM | Gene:56925 |
286 | 143-145 | Gene | denotes | μM | Gene:56925 |
287 | 88-90 | Gene | denotes | μM | Gene:56925 |
293 | 229-239 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
294 | 474-484 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
303 | 252-254 | Chemical | denotes | CQ | MESH:D002738 |
304 | 270-273 | Chemical | denotes | HCQ | MESH:D006886 |
308 | 21-41 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
311 | 45-51 | CellLine | denotes | VeroE6 | CVCL:0574 |
313 | 533-541 | Disease | denotes | COVID-19 | MESH:C000657245 |
358 | 623-624 | Gene | denotes | S | Gene:43740568 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T54 | 32-41 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
T55 | 52-57 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells |
T56 | 357-361 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell |
T57 | 549-558 | http://purl.obolibrary.org/obo/IDO_0000559 | denotes | Antiviral |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T24 | 52-57 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T25 | 357-361 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T52 | 21-31 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T53 | 32-41 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T54 | 229-239 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T55 | 474-484 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T56 | 533-541 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
282 | 101-103 | Gene | denotes | μM | Gene:56925 |
284 | 450-456 | Gene | denotes | CQ/HCQ | |
285 | 155-157 | Gene | denotes | μM | Gene:56925 |
286 | 143-145 | Gene | denotes | μM | Gene:56925 |
287 | 88-90 | Gene | denotes | μM | Gene:56925 |
293 | 229-239 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
294 | 474-484 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
303 | 252-254 | Chemical | denotes | CQ | MESH:D002738 |
304 | 270-273 | Chemical | denotes | HCQ | MESH:D006886 |
308 | 21-41 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
311 | 45-51 | CellLine | denotes | VeroE6 | CVCL:0574 |
313 | 533-541 | Disease | denotes | COVID-19 | MESH:C000657245 |
358 | 623-624 | Gene | denotes | S | Gene:43740568 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T55 | 194-283 | Sentence | denotes | These results showed that the anti-SARS-CoV-2 activity of CQ was worse than HCQ in vitro. |
T56 | 284-406 | Sentence | denotes | The conflicting results of these two studies may be related to different cell culture methods and experimental conditions. |
T57 | 407-494 | Sentence | denotes | In short, these in vitro studies show that CQ/HCQ have strong anti-SARS-CoV-2 activity. |
T58 | 496-498 | Sentence | denotes | 4. |
T59 | 500-541 | Sentence | denotes | Mechanisms of CQ/HCQ in treating COVID-19 |
T60 | 543-547 | Sentence | denotes | 4.1. |
T61 | 549-567 | Sentence | denotes | Antiviral activity |
T62 | 569-575 | Sentence | denotes | 4.1.1. |
T63 | 577-618 | Sentence | denotes | Hindrance of receptor recognition process |